Public Health Research

Effects of reduced-risk nicotine-delivery products on smoking prevalence and cigarette sales: an observational study

  • Type:
    Extended Research Article Our publication formats
  • Authors:
    Detailed Author information

    Francesca Pesola1, Anna Phillips-Waller1,*, Emma Beard2, Lion Shahab2, David Sweanor3, Martin Jarvis2, Peter Hajek1

    • 1 Wolfson Institute of Population Health, Queen Mary University of London, London, UK
    • 2 University College London, Tobacco and Alcohol Research Group, Department of Behavioural Science and Health, London, UK
    • 3 Faculty of Law and Centre for Health Law, Policy and Ethics, University of Ottawa, Ottawa, Canada
    • * Corresponding author email: a.phillips-waller@qmul.ac.uk
    • Disclosure of interests of authors

      Full disclosure of interests: Completed ICMJE forms for all authors, including all related interests, are available in the toolkit on the NIHR journals Library report publication page at https://doi.org/10.3310/RPDN7327.

      Primary conflict of interest:

      Peter Hajek has provided consultancy to and received research funding from Pfizer.

      Lion Shahab has received honoraria for talks, an unrestricted research grant and travel expenses to attend meetings and workshops from Pfizer and an honorarium to sit on an advisory panel from Johnson&Johnson, both pharmaceutical companies that make smoking-cessation products. He has acted as paid reviewer for grant-awarding bodies and as a paid consultant for health-care companies. Other research has been funded by the government, a community-interested company (National Centre for Smoking Cessation) and charitable sources.

      David Sweanor has received travel expenses for conferences to the Tobacco Harm Reduction – Challenges and Opportunities in the 21st Century conference (Tbilisi) and The Global Forum on Nicotine conference (Warsaw). He is an unpaid member on committees for pedestrian and cyclist issues and civil liberties. He is Chair of the advisory board of the Centre for Health Law, Policy and Ethics at the University of Ottawa, an adjunct law professor at the same university, on a global advisory committee for the Boston University School of Public Health, and belongs to/advises/funds groups working on a wide range of topics (e.g. nicotine, public health, transportation policy, homelessness, active transportation: all unpaid).

      All other authors have no conflicts to disclose.

  • Funding:
    Public Health Research programme
  • Journal:
  • Issue:
    Volume: 11, Issue: 7
  • Published:
  • Citation:
    Pesola F, Phillips-Waller A, Beard E, Shahab L, Sweanor D, Jarvis M, Hajek P. Effects of reduced-risk nicotine-delivery products on smoking prevalence and cigarette sales: an observational study. Public Health Res 2023;11(07). https://doi.org/10.3310/RPDN7327
  • DOI:
Crossmark status check